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Background: structural and 
functional brain imaging
brain imaging method could be defined as any
experimental technique that allows human (or animal)
brain structure or function to be studied, preferably in
vivo in the current context. Such a method should ideally
produce accurate timing (in the case of functional imag-
ing) and spatial localization (for both structural and func-
tional imaging) of cerebral function, structure, or changes
in these properties of the brain. The method should be
minimally invasive and repeatable (to facilitate use in
treatment monitoring and development of therapeutic
strategies). Current structural magnetic resonance imag-
ing (MRI) has good spatial resolution, is noninvasive, and
meets the above criteria well for structural analysis. In
contrast, no single technique currently in existence would
meet all these criteria in the case of functional imaging,
but the most common widely used methods are elec-
troencephalography (EEG), positron emission tomogra-
phy (PET), and functional magnetic resonance imaging
(fMRI). Of these three methods, EEG has been available
for the longest time (but arguably not so as a viable map-
ping method). PET has been available for the second-
longest period (in the order of four decades), and fMRI
is the newest widely used technique. PET is arguably the
most invasive (involving radioisotope administration)
and EEG makes the closest approach to measuring neu-
ronal activity directly (but has rather poor spatial map-
ping properties). As the location of cerebral activity and
changes in activity associated with changes in brain state
(either experimentally or illness-determined) seems to
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The main aim of this article is to discuss the current state
of in vivo brain imaging methods in the context of the
diagnosis and treatment of mental illness. The back-
ground to current practice is discussed, and the new
methods introduced which may have the capacity to
increase the relevance of magnetic resonance imaging,
particularly functional magnetic resonance imaging, for
clinical application. The main focus will be on magnetic
resonance imaging, but many of the comments have a
general relevance across imaging modalities.
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DCNS_43_4.qxd:DCNS#43  1/12/09  23:59  Page 389have been the priority in most of the research to date,
fMRI has emerged as the most widely used functional
brain mapping method.
Structural MRI (sMRI) has been a common tool for the
investigation of trauma and disease-related brain
changes for some considerable time, but fMRI is a more
recent addition to the MRI armory of methods. It has
been available for a little less than two decades, since
Ogawa et al
1 first coined the term BOLD (blood oxygen
level-dependent) contrast for what has become the most
widely used approach in use today. At first sight, BOLD
imaging has a number of shortcomings. At what is still
the most common field strength in MR scanners in clin-
ical use (1.5 Tesla), the signal changes following neural
activation are only a few percent. There are also a host
of artifacts that can interfere with the signal, most
notably head motion. The BOLD “signal” is also not a
direct readout of neuronal electrical activity, but rather
a downstream consequence of this activity, dependent
on the response of the circulatory system. Finally, there
is still a dispute about exactly what neural changes
underlie the BOLD response (for a recent viewpoint on
some of these issues, see Logothetis
2). Despite all these
apparent problems, BOLD fMRI has revolutionized the
study of human brain activity. It is noninvasive (does not
require administration of radioisotopes), can be per-
formed repeatedly on the same individuals, and uses
equipment that is increasingly widely available. There
have been tens of thousands of papers published in
which fMRI has been used to investigate a vast array of
aspects of human brain function.
Brain imaging and psychiatry
When MRI technology first became available to psychia-
try and neurology, one of the primary aims was to use this
new technology to establish what have often been
described as the “neural correlates” of various mental dis-
orders, ie, to determine the location and magnitude of
changes in brain structure or function compared with sub-
jects from a suitable reference population. This would facil-
itate the identification of “biomarkers” (objective quan-
tifiable changes in brain function) of the mental disorder
in question. The longer-term aim was then to use these bio-
markers to test the effects of drug treatment or behavioral
therapy, ie, to use them as quantitative measures of the
effectiveness of treatment in restoring “normality.”
As a research enterprise, the application of neuroimag-
ing with the above aims has resulted in a very large num-
ber of studies and an impressive number of research
publications in many of the major psychiatric and neu-
roscience journals, particularly in the case of fMRI. In
2003, barely a decade after the appearance of fMRI as a
viable imaging tool, it was possible to list, in a book enti-
tled Neuroimaging in Psychiatry
3 produced by a number
of my colleagues in London as well as eminent
researchers from other centers, hundreds of research
papers involving MR (as well as a large number from
longer established methodologies such as PET). Since
2003 the knowledge base in this area has continued to
expand at an impressive rate and, reading the literature
to date, one might well conclude that fMRI has had a
considerable impact on our understanding of abnor-
malities in brain function and structure. However, one
might ask a different but no less important question.
Standing as we do, almost two decades after the appear-
ance of fMRI and having (as we do) access to widely
available and reasonably reliable methods of analyzing
brain imaging data, has brain imaging started to make
an impact on the clinical issues of interest? Has brain
imaging materially altered the pressing issues of the
diagnosis and treatment of brain disorders? 
This issue was the subject of a recent editorial in the
British Journal of Psychiatry by Bullmore et al
4: “Why
psychiatry can’t afford to be neurophobic.” One of the
issues raised in that article is “the reality of psychiatric
practice in the UK, where there is currently agreed to
be no clear role for neuroimaging, biomarkers or
genetic testing.” The main question in relation to imag-
ing is why the large number of research studies have not
been translated into clear beneficial effects in clinical
practice. This is clearly a complex and multifactorial
issue, but the aim of the present contribution is to exam-
ine the simple question of whether neuroimaging is ask-
ing the appropriate questions of the data to maximize
its relevance to psychiatry and drug discovery and
development. For an interesting discussion of the gen-
eral issue of using neuroimaging to understand brain
function, see ref 5.
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Selected abbreviations and acronyms
fMRI functional magnetic resonance imaging
ROI region of interest
sMRI structural magnetic resonance imaging
SPM statistical parametric mapping
SVM support vector machine
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approaches to MRI analysis
In order to understand how the current approaches to
MRI analysis have arisen, one needs to return to the
period before fMRI was widely available, and brain acti-
vation and analysis was mainly undertaken using PET. The
technique, known as region of interest (ROI) analysis, was
the earliest to be employed and consisted, as its name sug-
gests, of picking, a priori, a region or regions of the brain
which were proposed, on the basis of previous findings or
hypotheses to respond to the experimental task being
studied. Typically, data would be averaged over the
ROI(s) and the change in blood flow related to task per-
formance would be studied, preferably with reference to
a control (nonresponding) region or regions. This method
remains arguably the simplest and one of the most statis-
tically powerful approaches to studying changes in brain
function and structure when the areas involved are well
known or strongly predicted a priori. However, universal
application of this method would entail a complete knowl-
edge of all the brain regions involved in normal brain
functions of interest, and (in psychiatry) when brain func-
tion or structure is abnormal. Given that we are still far
from such a state of knowledge, more exploratory
approaches were, and still are, needed in many cases.
Ideally, these methods needed to be able to explore activ-
ity changes at the limit of resolution of the brain images
(ie, at voxel level). In the late 1980s and early 1990s, Karl
Friston and his colleagues at the Hammersmith hospital
in London began to develop methods for the analysis of
changes in brain activation over the whole brain, an
endeavor which led to the development of the package
known as statistical parametric mapping (SPM—for
details see http://www.fil.ion.ucl.ac.uk/spm/doc/#history).
This package, freely available to researchers since 1991,
has become the most widely used approach for whole-
brain analysis of functional imaging data. In order to
achieve a principled approach to the problem, SPM devel-
oped a sophisticated way of dealing with the obviously
severe multiple comparison problem inherent in per-
forming tens of thousands of statistical tests, one at each
voxel.
6 This approach, using the statistical theory of
Gaussian random fields,
7 has earned Karl Friston deserved
recognition for revolutionizing the analysis of brain imag-
ing data. With the appearance of fMRI, the SPM package
was rapidly adapted to deal with the rather different char-
acteristics of the new data sets. Somewhat later, the possi-
bility of similarly analyzing structural changes voxel by
voxel led to the development of what is now known as
voxel-based morphometry or VBM. SPM was rapidly
applied to large numbers of structural and functional brain
imaging projects. It is the method of choice when changes
need to be investigated over the whole brain, either
because there is no strong prior hypothesis about the
areas that need to be studied, or because the distributed
nature of the expected changes makes ROI-based analy-
sis very challenging. On a more prosaic note, it also
removes much of the tedium (and potential error) of man-
ually defining ROIs on large, high-resolution MRI data
sets. Anyone who attempted to analyze structural MRI
data prior to the appearance of VBM might speculate that
the automated nature of this technique might have led
many researchers to take this route, even when an ROI
analysis might have been possible.
Since the early 1990s, there have been a large number of
technical developments in understanding, and dealing
with, sources of error in analyzing MRI data, and many
excellent packages are now available, but the main
analysis approach remains a suitably corrected voxel-by-
voxel exploration of whole-brain activations (or struc-
tural changes) with inferences as to which brain loca-
tions are exhibiting significant effects or changes in
effect brought about by the nature of the experimental
task undertaken or the membership of a particular sub-
ject group (eg, patient/control). The main approach
might be termed locationist and nonconnectionist, in
that it seeks to locate areas of significant response
(change) but ignores, by its independent voxel-by-voxel
analyses, interactions between brain regions, at least at
the primary phase of analysis. Note, however, that post-
hoc connectivity analyses are often undertaken in the
case of fMRI. Ignoring intervoxel interactions greatly
simplifies the analysis, but ignores our current knowl-
edge, suggesting that almost all significant brain activity
involves network or system level behavior. 
It is interesting to consider the pros and cons of this
piecewise approach to the analysis of brain function on
the current position of brain imaging vis à vis its uses in
psychiatry and drug discovery and testing. The obviously
positive aspects of 15 or so years of brain imaging
research using (predominantly mass-univariate) fMRI
are as follows. Firstly, our knowledge of the functional
neuroanatomy of the brain has been expanded consid-
erably. Secondly, if the multiple comparison problem
inherent in mass univariate analysis has been tackled in
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have identified should be relatively robust, as the ten-
dency would have been to make type II rather than type
I errors. On the other hand, the lack of consideration of
inter-regional interactions during whole-brain activation
detection will mean that we have missed some activa-
tions that might be weak but highly correlated between
brain regions. In other words, we might have under-
reported and underdetected the distributed networks
involved in many brain functions and in pathological
changes in these functions. In simple terms, we have
been “throwing away” useful information in the data sets
during analysis. A more important consideration, central
to the main theme of this article, is that, in the mass uni-
variate analysis, there is no combination of information
over the whole brain to assemble some sort of “figure of
merit” indicating how well our analysis results allow us
to, say, separate controls from patients, or drug respon-
ders from nonresponders. In other words, there is no
indication of how well the whole-brain data would allow
us to be confident that the pattern of activation was
characteristic of a patient rather than a healthy subject.
Instead of being able to make a prediction about an indi-
vidual being healthy or not on a network-wide basis, we
would instead be confined to making statements about
the overall separation of groups at a particular voxel or
in a particular region of interest, on the basis (typically)
of a t statistic.
New developments in analyzing brain 
imaging data: machine learning methods
These observations on the mainstream fMRI analysis
status quo have been made by a number of statisticians
and neuroscientists in recent years.
8,9 In response to the
issues described above, growing interest has now come
to be focused on a group of analysis techniques that
have been described as “brain-reading” or “brain-
decoding” methods
10 that belong to a broad group of
techniques known collectively as machine learning.
11
The basic idea of these methods is that, instead of ana-
lyzing the brain voxel by voxel, data from groups of
voxels (ROI) or indeed from the whole brain, are used
to train a computer program. In one set of classifica-
tion methods, the most common variant of which is
called the support vector machine (SVM), the program
will typically find a boundary (referred to as a hyper-
plane in the relevant literature because it exists in
high-dimensional space) between different classes of
data (eg, data from patients and data from controls
either from structural images of the same fMRI exper-
iment). Once this boundary has been located, predic-
tions can be made for data not in the training data set.
For example, having trained the program to distinguish
controls from depressed patients and define the opti-
mal hyperplane to achieve this distinction, a new sub-
ject could be classified as belonging to the “patient” or
the “control” class based on the relationship of their
data to the hyperplane. The specificity and sensitivity
of these predictions can be examined using standard-
ized statistical approaches. In the most common of
these, the so-called “leave one out” methods, the com-
puter program is training on all the subjects but one
and tested on the remaining individual. This is
repeated until all the subjects have been the “one left
out.” By averaging the results across all the tests it is
possible to compute the sensitivity and specificity,
where sensitivity here refers to the probability of cor-
rectly classifying a patient as a patient, and specificity
the probability of correctly classifying a control as a
control. If the data to be analyzed are obtained with a
continuous rating (depression scores) rather than a
classification variable (ill/not ill), then similar pro-
grams can operate on a data regression basis, learning
the association between the continuous rating and
brain structure or function. As well as providing infor-
mation that may clearly be of value in a clinical setting
in the form of classification accuracy, which communi-
cates the level of confidence we can have in the pre-
dictions made by this type of analysis, these “brain-
decoding” methods can also produce maps which
indicate the levels to which different brain regions are
involved in the classification accuracy that has been
achieved. However, here a note of caution is in order.
Unlike the maps produced by the more commonly
used mass-univariate methods which can be unequiv-
ocally interpreted in terms of the size of the effect (eg,
difference in response between groups) at each voxel,
the maps produced by the machine learning methods
explicitly contain the effects of interactions between
voxels or brain regions. In other words, a particular
voxel could be important in distinguishing two groups
either because there is a large difference in function or
structure at that point or because there is a small dif-
ference that is highly correlated with those in many
Translational research
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correlations. There are two main consequences arising
from this. The first is that the maps may be inherently
more sensitive in depicting effects than those that we
may be accustomed to seeing (though this is debated
and is still undergoing detailed study). The second is
that, unlike univariate maps, that can be subjected to
statistical thresholding at a particular P value, thresh-
olding these multivariate maps is more challenging,
and the most effective way to accomplish this is an
active area of investigation.
To summarize the above discussion, both the mass-uni-
variate and multivariate “brain reading” methods of ana-
lyzing MRI data can give information about the location
of disease-related changes in structure or function. The
univariate methods are in fact easier to interpret, but
may be less sensitive in detecting small changes to dis-
tributed systems. Few would argue, however, that if
properly carried out, both approaches can potentially
produce useful maps.
It is valuable at this point, however, to consider the rela-
tionship between producing a reliable map and estab-
lishing a usable biomarker for a psychiatric illness. The
concept of a biomarker contains within it the idea of
classification. It associates a pattern of changes in brain
structure or function with a particular mental state. This
is in fact the core idea of the “brain-reading” method-
ologies, as stated above. However, without knowledge of
the classification accuracy associated with the map of
brain changes, the map itself has little value. In a dis-
tinction between two classes, a random allocation
process would produce a classification accuracy of 50%.
A useful biomarker would be a pattern of changes with
a classification accuracy of such a level that its proba-
bility of arising by chance would be very small. We can
carry out such a test very easily. Having determined the
classification accuracy as described earlier, we the ran-
domly allocate the data to the two classes of interest
(thus achieving the null hypothesis of no difference
between the classes) and repeat the “leave one out” test-
ing. If we do this a very large number of times, we can
establish how likely the classification process is to pro-
duce the original classification accuracy under the null
hypothesis of no difference between the classes. In sim-
ple terms, we can see how far away from chance the clas-
sification lies. The further this is, the “cleaner” the sep-
aration between the groups achieved by the imaging
“biomarker.”
Machine learning in current image 
analysis—a change of emphasis?
Although “brain reading” using machine learning meth-
ods (often also referred to as pattern classification meth-
ods) is currently arousing a good deal of interest, their
use in the investigation of brain imaging is not new. In
fact, they were used as long ago as the 1990s to investi-
gate PET data.
12,13 However, functional and structural
brain imaging research has produced a host of new and
interesting analysis methods over the last two decades.
The reasons why some methods become widely used
whereas others do not is a topic of considerable interest.
O'Toole and colleagues
8 devoted considerable space to
discussing this issue and raised issues of what will move
researchers out of their “comfort zone” to a new and
potentially useful way of using their data. Given the
availability of high-quality packages such as SPM, where
mass-univariate analysis is efficiently implemented, and
which are well-known and respected by neuroimagers,
new methods have to be easy to use and to offer con-
siderable added value to justify the investment in using
them.
Why then does the author of the current article believe
that machine learning methods may be widely taken up
when many other promising methods have not? In the
early 2000s considerable interest in questions of
face/object recognition in the visual cortex led to some
fascinating experiments. Notably, a very elegant study of
face and object processing in the visual cortex by Haxby
and his colleagues appeared.
14 This paper did not use
machine learning methods, but introduced the idea of
associating brain states (recognition of different types of
object) with distributed patterns of brain activity. Shortly
afterwards, in 2002, Golland et al wrote a highly inter-
esting account of the use of classifiers in brain imaging,
15
introducing the use of the SVM, and in 2003 Cox and
Savoy
10 used an SVM (see above) in the same area of
research as Haxby.
14 It was clear from these data that
information might be available in distributed patterns of
brain activity that were not accessible by considering
each voxel in isolation. Moreover, this information could
aid classification. This was a way, not simply of locating
functional or structural changes in the brain due to illness
or a change in an experimental paradigm, but of using
data from many voxels to explicitly classify brain data
according to the group to which they belonged. A num-
ber of groups then began to realize that these ideas were
MRI analysis—impact on clinical applications - Brammer Dialogues in Clinical Neuroscience - Vol 11 . No. 4 . 2009
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than a statistically unconnected set of results from inde-
pendently analyzed brain regions. Machine learning
methods were soon applied to analysis of fMRI data,
16,17
demonstrating the power to achieve good classification
accuracies based on networks located in believable brain
regions. It is but a small step from this point to the idea
of automated diagnosis. In the area of structural MRI,
Alzheimer's disease has been one of the major targets for
this latest phase of applications of machine learning.
18,19
This is perhaps understandable, given that it gives rise to
both distributed and major effects on gray matter den-
sity, making it an obvious target for a multivariate classi-
fication method. The use of fMRI for diagnostic purposes
has also been investigated using SVM.
20,21 Machine-learn-
ing based classifiers are currently achieving accuracies of
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Figure 1. Data flow in a simple 2-task functional magnetic resonance imaging (fMRI) experiment (alternating blocks of each task) through traditional
univariate analysis with general linear modeling (GLM) and support vector machine (SVM) analysis. The univariate approach analyses indi-
vidual voxels using time points when task 1 is being performed and time points where task 2 is being performed, contrasting the two using
a simple statistical test (eg, a t test) with a correction for the number of voxels analyzed. The output is a map of regions where the responses
to the two tasks are significantly different. SVM-based analysis takes whole-brain volumes when task 1 is being performed and whole-brain
volumes when task 2 is being performed and “trains” a computer program to associate  patterns of fMRI response with each task. The out-
puts are a map of the regions which discriminate between the two tasks and a measure of how well the two tasks are discriminated on the
basis of the whole brain data. After training, the task being performed can be predicted purely from the fMRI data. For group separation,
tasks 1 and 2 can be replaced by groups 1 and 2 ( eg, patients/controls) performing a given task or structural MRI data from the two groups.
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and active research in this area is extending the armory
of methods beyond categorical classification to proba-
bilistic output using techniques such as Gaussian Process
methods.
22 Other techniques of interest include single-
class SVM in which the goal is outlier or novelty detec-
tion. This method has considerable promise for detection
of deviations from statistical homogeneity in clinical pop-
ulations.
In a recent demonstration of the possibilities for
machine learning, Sato and his colleagues carried out an
interesting experiment.
23 They first trained a computer
program (using a technique called maximum entropy
linear discriminant analysis) to recognize the association
between age and brain activation changes during per-
formance of a motor (finger-tapping task). They were
then able to predict the ages of subjects not included in
the training purely from their brain activation data. If
one imagines the association computed in this experi-
ment as a biomarker for age, and then extends the logic
to other areas (eg, changes in depression) one can appre-
ciate the possibilities of the method. 
Some of the most exciting possibilities of machine learn-
ing methods in clinical practice stem from the ideas
raised in the two previous paragraphs. One is that we
may be able to locate individual patients on a continuum
of brain structural or functional abnormalities that are
correlated with illness severity. This would be a great
advance on simply categorizing an individual as belong-
ing to the group of “controls” or the group of “patients.”
We would also be able to identify patients who, on the
basis of their brain structure or function, appeared to be
atypical of their diagnostic group.  The second is that this
“continuum” or probabilistic rather than categorical
approach, could be extended from diagnosis to response
prediction—personalization of treatment. The probabil-
ity that a given patient might be a “responder” rather
than a “nonresponder” based on objective measurement
of brain structure or function would be a valuable
adjunct to the choice and direction of treatment.
In order to make these new methods available on a wide
basis, a number of groups are also actively developing
toolboxes with user-friendly interfaces. Also, in order to
avoid repetition of already time-consuming image pro-
cessing, these toolboxes are often being designed to
accept data from widely used preprocessing streams in
packages such as SPM.
Conclusion
Seventeen years ago, it was felt that fMRI might revo-
lutionize the study of human brain activity.
1,24 Arguably,
this has proved to be the case. It was also felt by many
that fMRI might prove to be an invaluable clinical for
the investigation and treatment of mental illness. There
are many who would argue that has not proved to be the
case. Kosslyn in 1999
5 asked “If fMRI is the answer—
what is the question?” With machine learning, perhaps
fMRI may be able to answer more of the questions that
we wish to ask.❏
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El papel de las neuroimágenes en el 
diagnóstico y en la medicina personalizada:
situación actual y probables proyecciones
futuras
El objetivo principal de este artículo es analizar la
situación actual de los métodos de neuroimágenes
in vivo en el contexto del diagnóstico y del trata-
miento de las enfermedades mentales. Se discute el
fundamento de la práctica actual y los nuevos
métodos introducidos, los que pueden tener la
capacidad de aumentar la importancia de las imá-
genes de resonancia magnética, en especial de la
resonancia funcional, para la aplicación clínica. El
foco principal estará en las imágenes de resonancia
magnética, pero muchos de los comentarios tienen
una relevancia general para las distintas modalida-
des de imágenes. 
Rôle de la neuro-imagerie dans le diagnostic
et la médecine personalisée: position
actuelle et perspectives éventuelles
Cet article vise principalement à examiner la place
actuelle des méthodes d’imagerie cérébrale in vivo
dans le contexte du diagnostic et du traitement des
maladies mentales : une discussion du  cadre des
pratiques actuelles est proposée, ainsi qu'une intro-
duction aux  nouvelles méthodes qui pourraient
augmenter la pertinence de l’imagerie par réso-
nance magnétique, plus particulièrement  l’IRM
fonctionnelle,en ce qui concerne ses  applications
cliniques. Le sujet principal en est l'IRM, mais un
grand nombre des commentaires sont également
valables pour d'autres méthodes d'imagerie. 
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